News

Net profit of Aarti Drugs declined 12.20% to Rs 55.19 crore in the quarter ended March 2026 as against Rs 62.86 crore during the previous quarter ended March 2025. Sales rose 6.43% to Rs 720.30 crore in the quarter ended March 2026 as against Rs 676.76 crore during the previous quarter ended March 2025.For the full year,net profit rose 15.91% to Rs 194.92 crore in the year ended March 2026 as against Rs 168.16 crore during the previous year ended March 2025. Sales rose 7.47% to Rs 2565.31 crore in the year ended March 2026 as against Rs 2387.03 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales720.30676.76 6 2565.312387.03 7 OPM %13.3013.79 -12.0512.03 - PBDT88.4086.04 3 277.87267.55 4 PBT70.3671.16 -1 210.90211.77 0 NP55.1962.86 -12 194.92168.16 16 Powered by Capital Market - Live News

Net profit of Aarti Drugs declined 26.87% to Rs 44.96 crore in the quarter ended March 2026 as against Rs 61.48 crore during the previous quarter ended March 2025. Sales rose 1.40% to Rs 631.68 crore in the quarter ended March 2026 as against Rs 622.96 crore during the previous quarter ended March 2025.For the full year,net profit rose 7.57% to Rs 169.22 crore in the year ended March 2026 as against Rs 157.31 crore during the previous year ended March 2025. Sales rose 3.99% to Rs 2260.39 crore in the year ended March 2026 as against Rs 2173.65 crore during the previous year ended March 2025. ParticularsQuarter EndedYear EndedMar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var. Sales631.68622.96 1 2260.392173.65 4 OPM %12.5514.23 -11.5412.08 - PBDT73.5282.88 -11 236.95246.54 -4 PBT58.5770.67 -17 181.31198.75 -9 NP44.9661.48 -27 169.22157.31 8 Powered by Capital Market - Live News

Aarti Drugs will hold a meeting of the Board of Directors of the Company on 15 May 2026.

Aarti Drugs announced that the Board of Directors of the Company at its meeting held on 3 February 2026, inter alia, have recommended the interim dividend of Rs 2 per equity Share (i.e. 20%) , subject to the approval of the shareholders.Powered by Capital Market - Live News

Net profit of Aarti Drugs rose 9.42% to Rs 40.54 crore in the quarter ended December 2025 as against Rs 37.05 crore during the previous quarter ended December 2024. Sales rose 8.10% to Rs 601.71 crore in the quarter ended December 2025 as against Rs 556.60 crore during the previous quarter ended December 2024. ParticularsQuarter EndedDec. 2025Dec. 2024% Var. Sales601.71556.60 8 OPM %9.1511.09 - PBDT46.9764.56 -27 PBT29.0250.76 -43 NP40.5437.05 9 Powered by Capital Market - Live News